Close

Canaccord Genuity Q3 Biotech Results Preview Oct 25, 2011 11:47AM
Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); Adcetris H2 Sales Estimate Preview Oct 21, 2011 09:01AM
Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); Adcetris Launch Ahead Aug 23, 2011 08:30AM
Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); Adcetris Label Supports Limited Market Opportunity Aug 22, 2011 08:43AM
Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); Profile Shift Expected to Weigh on Shares Jul 19, 2011 08:31AM


Jul 11, 2011 08:38AM Canaccord Genuity Reiterates a 'Sell' on Seattle Genetics (SGEN); Adcetris ODAC Panel Preview
Jun 16, 2011 08:25AM Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); Current Valuation Overrepresents Ultimate Market Opportunity
Feb 18, 2011 10:01AM Canaccord Genuity Reiterates a 'Sell' on Seattle Genetics (SGEN); ADC Technology Drug Candidate Falls Flat
Feb 9, 2011 11:48AM Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); SGN-35 Market Potential Concerns Persist
Nov 22, 2010 11:05AM Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); ASH Preview: High Expectations Going Into Data Presentations
Nov 2, 2010 03:28PM Canaccord Genuity Downgrades Seattle Genetics (SGEN) from Buy to Sell; SGN-35 Revaluated